Latest news
Philadelphia's BriaCell Gets FDA Clearance to Take Its Cancer Immunotherapy Platform Into Prostate Cancer - BioBuzzBioBuzz · Fri, 07 Aug 2026 15:36:03 GMTCellFiber and Tidewave Bio Enter Collaboration to Evaluate Scalable 3D Manufacturing for Next-Generation Solid Tumor Immunotherapy - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 00:12:54 GMT